KATHERYN FERNANDEZ PAUL: Open Payments
NPI 1902116007 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$643 in 24 payments from 6 companies in 2025. Trend: 2023 $3,608 · 2024 $1,490 · 2025 $643
Food & beverage: $643
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 4 | $169 |
| Teva Pharmaceuticals USA, Inc. | 6 | $141 |
| Axsome Therapeutics, Inc. | 7 | $140 |
| Lundbeck LLC | 4 | $127 |
| Janssen Pharmaceuticals, Inc | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: Qelbree, AUSTEDO XR, Auvelity, REXULTI, SPRAVATO, CAPLYTA, INVEGA SUSTENNA.
Industry payments across FL — which companies pay providers there.
